Sign Up to like & get
recommendations!
0
Published in 2017 at "Investigational New Drugs"
DOI: 10.1007/s10637-017-0528-y
Abstract: SummaryVinflunine is to date the only registered agent for second-line treatment of metastatic urothelial cell carcinoma (UCC) in Europe. However, the effect is modest. Pemetrexed has demonstrated some single-agent activity in this disease entity. In…
read more here.
Keywords:
urothelial cell;
cell carcinoma;
treatment;
vinflunine ... See more keywords